| RS2134611028 |
COL17A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS2134611494 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2134611976 |
PDE6C
|
Health Risk |
Likely pathogenic |
Abnormality of the eye, Abnormality of the eye |
| RS2134612747 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2134613305 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS2134617509 |
PDE6C
|
Health Risk |
Pathogenic |
— |
| RS2134623972 |
EBF3
|
Health Risk |
Likely pathogenic |
Hypotonia, ataxia |
| RS2134626266 |
SLC37A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital disorder of glycosylation, type IIw |
| RS2134626765 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134628172 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134631019 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS2134631242 |
SLC37A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134631556 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134631619 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134633522 |
DCHS1
|
Health Risk |
Pathogenic |
— |
| RS2134633746 |
DCHS1
|
Health Risk |
Pathogenic |
Van Maldergem syndrome 1, Van Maldergem syndrome 1 |
| RS2134633831 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134633858 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134633880 |
SLC37A4
|
Health Risk |
Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134634960 |
DCHS1
|
Health Risk |
Pathogenic |
Van Maldergem syndrome 1, Van Maldergem syndrome 1 |
| RS2134635160 |
SLC37A4
|
Health Risk |
Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134637643 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134638421 |
SLC37A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134639714 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134640168 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134643885 |
DCHS1
|
Health Risk |
Pathogenic |
— |
| RS2134644045 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134644472 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS2134654635 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2134655291 |
EBF3
|
Health Risk |
Pathogenic |
— |
| RS2134655427 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2134656843 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2134657107 |
PAX6
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2134658539 |
EBF3
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2134659091 |
EBF3
|
Health Risk |
Pathogenic |
Hypotonia, ataxia |
| RS2134659487 |
EBF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypotonia, ataxia |
| RS2134659512 |
EBF3
|
Health Risk |
Likely pathogenic |
Hypotonia, ataxia |
| RS2134662046 |
EBF3
|
Health Risk |
Pathogenic |
— |
| RS2134667452 |
DYNC2H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS2134678958 |
NHLRC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibrosis, neurodegeneration |
| RS2134689565 |
BSCL2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2134690008 |
BSCL2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2134691627 |
PEX16
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2134692559 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2134692847 |
PEX16
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2134693013 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2134694006 |
PEX16
|
Health Risk |
Likely pathogenic |
— |
| RS2134694075 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group C, Fanconi anemia complementation group C |
| RS2134695130 |
BSCL2;HNRNPUL2-BSCL2
|
Health Risk |
Likely pathogenic |
Congenital generalized lipodystrophy type 2, Congenital generalized lipodystrophy type 2 |
| RS2134695257 |
PEX16
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 8A (Zellweger), Peroxisome biogenesis disorder |
| RS2134695309 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2134698831 |
PACS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schuurs-Hoeijmakers syndrome, Schuurs-Hoeijmakers syndrome |
| RS2134699162 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2134699707 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2134706153 |
NKX6-2
|
Health Risk |
Likely pathogenic |
Spastic ataxia 8, autosomal recessive |
| RS2134706311 |
NKX6-2
|
Health Risk |
Pathogenic |
Spastic ataxia 8, autosomal recessive |
| RS2134706418 |
NKX6-2
|
Health Risk |
Pathogenic |
Spastic ataxia 8, autosomal recessive |
| RS2134706667 |
NHLRC2
|
Health Risk |
Pathogenic |
Fibrosis, neurodegeneration |
| RS2134707034 |
NKX6-2
|
Health Risk |
Pathogenic |
— |
| RS2134707158 |
NKX6-2
|
Health Risk |
Pathogenic |
Spastic ataxia 8, autosomal recessive |
| RS2134714165 |
PCDH15
|
Health Risk |
Pathogenic |
Usher syndrome type 1F, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2134714388 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2134724901 |
SMC3
|
Health Risk |
Pathogenic |
— |
| RS2134734280 |
MPZL2
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal recessive 111 |
| RS2134735270 |
VPS11
|
Health Risk |
Pathogenic |
Dystonia 32, Dystonia 32 |
| RS2134735614 |
SMC3
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 3, Cornelia de Lange syndrome 3 |
| RS2134735819 |
PACS1
|
Health Risk |
Pathogenic |
Schuurs-Hoeijmakers syndrome, Schuurs-Hoeijmakers syndrome |
| RS2134740210 |
SMC3
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 3, Cornelia de Lange syndrome 3 |
| RS2134745289 |
SMC3
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2134745322 |
SMC3
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 3, Cornelia de Lange syndrome 3 |
| RS2134747667 |
EFEMP2
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal recessive |
| RS2134748638 |
PACS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schuurs-Hoeijmakers syndrome, Inborn genetic diseases |
| RS2134750930 |
SMC3
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 3, Cornelia de Lange syndrome 3 |
| RS2134754195 |
SMC3
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 3, Cornelia de Lange syndrome 3 |
| RS2134761257 |
ACAT1
|
Health Risk |
Pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134765690 |
BBS1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome 1 |
| RS2134766485 |
VPS11
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 12, Hypomyelinating leukodystrophy 12 |
| RS2134768525 |
ACAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134768688 |
ACAT1
|
Health Risk |
Pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134768866 |
ACAT1
|
Health Risk |
Pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134770866 |
CTSC
|
Health Risk |
Pathogenic |
Periodontitis, aggressive 1 |
| RS2134771570 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS2134771631 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2134772571 |
ACAT1
|
Health Risk |
Pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134773243 |
ACAT1
|
Health Risk |
Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134773913 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2134775125 |
LRP4
|
Health Risk |
Pathogenic |
Cenani-Lenz syndactyly syndrome, Cenani-Lenz syndactyly syndrome |
| RS2134780429 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS2134780623 |
ACAT1
|
Health Risk |
Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134783712 |
KLC2
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2134784600 |
BBS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome |
| RS2134791556 |
ACAT1
|
Health Risk |
Pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134791667 |
ACAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134791703 |
ACAT1
|
Health Risk |
Pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134791752 |
ACAT1
|
Health Risk |
Pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134792820 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2134797289 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2134797745 |
ACAT1
|
Health Risk |
Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS2134797993 |
BBS1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2134823550 |
SORL1
|
Health Risk |
Pathogenic |
— |